These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23112853)

  • 1. Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?
    Miller AM; Purves D; McConnachie A; Asquith DL; Batty GD; Burns H; Cavanagh J; Ford I; McLean JS; Packard CJ; Shiels PG; Turner H; Velupillai YN; Deans KA; Welsh P; McInnes IB; Sattar N
    PLoS One; 2012; 7(10):e47830. PubMed ID: 23112853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
    Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
    Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble ST2 is associated with increased carotid intima-media thickness in patients with type 2 diabetes mellitus: A case-control study.
    Hu X; Zhang H; Song Y; Yang Q; Zhuang L; Jin G; Zhang S; Sun W; Shi Z
    Medicine (Baltimore); 2020 Jan; 99(5):e18940. PubMed ID: 32000412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.
    Shen J; Shang Q; Wong CK; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Yu SL; Kuan WP; Yu CM; Tam LS
    Semin Arthritis Rheum; 2015 Aug; 45(1):18-27. PubMed ID: 25798875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes of soluble ST2 after cardiovascular interventions.
    Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
    Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.
    Willems S; Quax PH; de Borst GJ; de Vries JP; Moll FL; de Kleijn DP; Hoefer IE; Pasterkamp G
    Atherosclerosis; 2013 Nov; 231(1):48-53. PubMed ID: 24125409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
    Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
    Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes.
    Lin YH; Zhang RC; Hou LB; Wang KJ; Ye ZN; Huang T; Zhang J; Chen X; Kang JS
    Diabetes Res Clin Pract; 2016 Aug; 118():140-5. PubMed ID: 27371779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble ST2 predicts elevated SBP in the community.
    Ho JE; Larson MG; Ghorbani A; Cheng S; Vasan RS; Wang TJ; Januzzi JL
    J Hypertens; 2013 Jul; 31(7):1431-6; discussion 1436. PubMed ID: 23615326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.
    Coglianese EE; Larson MG; Vasan RS; Ho JE; Ghorbani A; McCabe EL; Cheng S; Fradley MG; Kretschman D; Gao W; O'Connor G; Wang TJ; Januzzi JL
    Clin Chem; 2012 Dec; 58(12):1673-81. PubMed ID: 23065477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.
    Shen J; Shang Q; Wong CK; Li EK; Kun EW; Cheng IT; Li M; Li TK; Zhu TY; Yu CM; Qin L; Tam LS
    Sci Rep; 2016 Aug; 6():32116. PubMed ID: 27554830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the Dallas Heart Study.
    Chen LQ; de Lemos JA; Das SR; Ayers CR; Rohatgi A
    Clin Chem; 2013 Mar; 59(3):536-46. PubMed ID: 23220272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study.
    Filali Y; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2021 Jul; 81(4):324-331. PubMed ID: 33794701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.
    Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between lipoprotein (a) and carotid atherosclerosis in patients with type 2 diabetes without pre-existing cardiovascular disease: A cross-sectional study.
    Jun JE; Kang H; Hwang YC; Ahn KJ; Chung HY; Jeong IK
    Diabetes Res Clin Pract; 2021 Jan; 171():108622. PubMed ID: 33316308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.
    Wagenaar JF; Gasem MH; Goris MG; Leeflang M; Hartskeerl RA; van der Poll T; van 't Veer C; van Gorp EC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e453. PubMed ID: 19488407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of reference intervals for soluble ST2 from a United States population.
    Lu J; Snider JV; Grenache DG
    Clin Chim Acta; 2010 Nov; 411(21-22):1825-6. PubMed ID: 20654603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ST2: a new and promising activity marker in ulcerative colitis.
    Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
    World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST2 and IL-33 in pregnancy and pre-eclampsia.
    Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
    PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.